ArticleCommunications medicine2026
Exome sequencing identifies known and candidate genes in hearing impairment in Cameroon.
Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHearing impairment (HI) is one of the most common sensory disorders globally. There is limited data on the genetics of HI in Africa. We aim to identify the genetic causes of HI in Cameroon.
methodsWe used whole-exome sequencing (WES) to study the cause of HI in multiplex families from Cameroon. Cell-based experiments using HEK293T assessed the pathogenicity of targeted variants, and a knockout mouse model was used to investigate a candidate gene.
resultsHere, we report forty-six multiplex families totaling 106 affected individuals with HI. Most families present with non-syndromic HI (NSHI) (87%, n = 40/46). Causative variants in known genes are identified in 76% (n = 35/46) of families, including nine genes that cause both syndromic HI (SHI) and NSHI, ten that underlie NSHI, and six that cause SHI. MYO15A and TMC1 are the most common genes underlying HI and are observed in six and three families, respectively. Three candidate genes (SUN2, TGM6, and TMC3) are identified. In vitro studies find that a biallelic variant in SUN2 [c.475 G > A:p.(Val159Ile); NM_015374.3] leads to mislocalization and decreased expression in HEK293T cells. In mice, SUN2 protein expression localizes explicitly to the supporting cells of the inner hair cells. Auditory thresholds of the Sun2 knockout mice are comparable to those of wild-type, suggesting that SUN2 is not a credible HI gene.
conclusionThis study reports a high diagnostic rate using WES for HI and highlights the opportunity for variant and gene discoveries in African populations. These findings inform the prospects for gene therapy in HI.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.